Smith & Nephew plc (SNN)
Makes surgical implants and wound care products for orthopedic and trauma injuries.
$32.14+0.03%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+4.2%
The outlook
Smith & Nephew trades at $32.14, sitting in the lower-middle portion of its 52-week range with mixed price momentum against its moving averages. Analyst consensus rates the stock neutrally, with an average price target about 6% above the current level. The trailing P/E of 22.5 reflects moderate valuation in the healthcare sector context.
What’s behind the score
Price trendMixed vs its moving averages
52-week range35% of the way from its 52-week low to high
Price targetAvg target +6% vs current price
Analyst price target
~12-month · 5 analysts$34.07average target+6.0% vs now
Now $32.14
Low $30.00High $38.40
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$13.52B
52-wk high
$38.79
52-wk low
$28.56
50-day avg
$30.27
200-day avg
$32.79
Trailing P/E
22.5